Detecting curable disease following hepatectomy for colorectal metastases

dc.contributor.authorMetcalfe, M.
dc.contributor.authorMann, C.
dc.contributor.authorMullin, E.
dc.contributor.authorMaddern, G.
dc.date.issued2005
dc.description.abstractIntroduction: Although resection may be curative for patients with hepatic colorectal metastases, recurrence occurs in the majority. Recurrence is occasionally amenable to repeated resection. The aim of the present study was to evaluate which modalities, at what intervals, detected potentially curable resection. Methods: The records of patients undergoing hepatectomy for colorectal metastases over 10 years in one centre were retrospectively reviewed to determine when and how recurrence was diagnosed. Specific attention was paid to the detection of potentially curable disease. Results: Of 41 recurrences, 22 occurred in the first year postoperatively, 21 of which were suitable for palliative treatment only. Ten of 19 recurrences occurring after 1 year underwent potentially curative intervention, 10 were diagnosed by computed tomography (CT). Carcinoembryonic antigen did not diagnose any curable recurrence. Conclusions: A follow-up protocol is proposed, based on annual CT.
dc.description.statementofresponsibilityMatthew Metcalfe, Chris Mann, Emma Mullin and Guy Maddern
dc.identifier.citationANZ Journal of Surgery, 2005; 75(7):524-527
dc.identifier.doi10.1111/j.1445-2197.2005.03421.x
dc.identifier.issn1445-1433
dc.identifier.issn1445-2197
dc.identifier.orcidMaddern, G. [0000-0003-2064-181X]
dc.identifier.urihttp://hdl.handle.net/2440/16648
dc.language.isoen
dc.publisherBlackwell Science Asia
dc.source.urihttps://doi.org/10.1111/j.1445-2197.2005.03421.x
dc.subjectCarcinoembryonic antigen
dc.subjectcolorectal metastases
dc.subjectcomputed tomography
dc.subjectfollow up
dc.subjecthepatectomy
dc.subjectrecurrence
dc.titleDetecting curable disease following hepatectomy for colorectal metastases
dc.typeJournal article
pubs.publication-statusPublished

Files